The latest drugs to be added to the interaction checker include an analgesic, two cancer therapies and three gastrointestinal agents. The new drugs and their classes are:
- Ketoprofen (Analgesics)
- Enfortumab vedotin (Cancer Therapies)
- Erdafitinib (Cancer Therapies)
- Hyoscine (Scopolamine) (Gastrointestinal Agents, anti-emetics)
- Hyoscine hydrobromide (Scopolamine hydrobromide) (Gastrointestinal Agents, anti-emetics)
- Hyoscine butylbromide (Butylscopolamine) (Gastrointestinal Agents)
